Facebook
X
LinkedIn
ForwardSummit of the Americas on Immunotherapies for Hematologic Malignancies, Third Annual
Symposium Guide
Saturday, April 9, 2022
Claim CME Credit
MOBILE USERS: Click on the button below and enter the six-digit code provided at the symposium to receive your credit.
DESKTOP USERS: Scan the QR code shown below with your mobile phone, and enter the six-digit code provided at the symposium to receive your credit.
Evaluation
Click on the button below to complete today's evaluation. The evaluation will be available at the conclusion of today's program.
Hotel Map
Presentations
Session Title
Download
8:15 - 8:45 a.m.
The Role of Intestinal Microbiome in Hematopoietic Stem Cell Transplantation and Immuno-oncology
Marcel van den Brink, M.D., Ph.D.
The Role of Intestinal Microbiome in Hematopoietic Stem Cell Transplantation and Immuno-oncology
Marcel van den Brink, M.D., Ph.D.
8:45 - 9:15 a.m.
The Impact of CAR T-Cell Therapy on Hematopoietic Stem Cell Transplantation
Robert Soiffer, M.D.
The Impact of CAR T-Cell Therapy on Hematopoietic Stem Cell Transplantation
Robert Soiffer, M.D.
9:15 - 10:00 a.m.
Keynote Address - Next Steps in CAR T-cell Therapies
Michel Sadelain, M.D., Ph.D.
Keynote Address - Next Steps in CAR T-cell Therapies
Michel Sadelain, M.D., Ph.D.
11:30 a.m. - 12:00 p.m.
Optimizing CAR Cell-based Immunotherapy by Targeting the Cancer Cell “Sugar-Coat”
Robert Sackstein M.D., Ph.D.
Optimizing CAR Cell-based Immunotherapy by Targeting the Cancer Cell “Sugar-Coat”
Robert Sackstein M.D., Ph.D.
12:00 - 12:30 p.m.
Novel Approaches of CAR T-cell Therapies for AML
Siddhartha Mukherjee, M.D.
Novel Approaches of CAR T-cell Therapies for AML
Siddhartha Mukherjee, M.D.
12:30 p.m. - 1:00 p.m.
Do CARs Always Have to Be T-Cells
Paul Lin, M.D.
Do CARs Always Have to Be T-Cells
Paul Lin, M.D.